Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Total Debt: 2016-2018

Historic Total Debt for Niagen Bioscience (NAGE) over the last 3 years, with Dec 2018 value amounting to $137,000.

  • Niagen Bioscience's Total Debt fell 55.81% to $137,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $137,000, marking a year-over-year decrease of 55.81%. This contributed to the annual value of $137,000 for FY2018, which is 55.81% down from last year.
  • Niagen Bioscience's Total Debt amounted to $137,000 in FY2018, which was down 55.81% from $310,000 recorded in FY2017.
  • Niagen Bioscience's 5-year Total Debt high stood at $4.9 million for FY2016, and its period low was $137,000 during FY2018.
  • Over the past 3 years, Niagen Bioscience's median Total Debt value was $327,000 (recorded in 2016), while the average stood at $1.4 million.
  • Data for Niagen Bioscience's Total Debt shows a maximum YoY crashed of 92.94% (in 2016) over the last 5 years.
  • Niagen Bioscience's Total Debt (Yearly) stood at $4.9 million in 2016, then slumped by 92.94% to $344,000 in 2016, then decreased by 9.88% to $310,000 in 2017, then plummeted by 55.81% to $137,000 in 2018.